e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Genetics, genomics and exposures in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of novel genes related to airway obstruction in never-smokers
Diana van der Plaat (Groningen, Netherlands), D.A. Van der Plaat, K. De Jong, J.M. Vonk, C.C. Van Diemen, C.M. Van Duijn, L. Lahousse, G.G. Brusselle, D.S. Postma, H.M. Boezen
Source:
International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Session:
Genetics, genomics and exposures in asthma and COPD
Session type:
Oral Presentation
Number:
1459
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Diana van der Plaat (Groningen, Netherlands), D.A. Van der Plaat, K. De Jong, J.M. Vonk, C.C. Van Diemen, C.M. Van Duijn, L. Lahousse, G.G. Brusselle, D.S. Postma, H.M. Boezen. Identification of novel genes related to airway obstruction in never-smokers. Eur Respir J 2015; 46: Suppl. 59, 1459
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Expression of genes associated with neurogenic inflammation in pediatric asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Differential bronchial epithelial gene expression in COPD versus controls
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Association between candidate gene polymorphisms and asthma severity in adults. A Bayesian analysis
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
SNPs in SPINK5 gene region are associated with asthma severity: Preliminary results from the gene environment interactions in respiratory diseases (GEIRD) study
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Role of TRPV1 and TRPV2 gene polymorphisms in the development of airway hyperresponsiveness to osmotic stimuli in patients with asthma
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Characterization and functional progression of COPD in young adults (early COPD)
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Distribution of blood eosinophil in COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
GLCCI1
variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Effect of TRPV4 gene polymorphisms on osmotic airway hyperresponsiveness in patients with asthma
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
TRPM8
gene polymorphisms and their relation to cold airway hyperresponsiveness in patients with bronchial asthma
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Cellular mechanisms underlying CCSP SNP association with chronic airway diseases
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model)
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept